New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, November 10, 2026

Back to the front page

From X

@DOMOCAPITAL

DOMO Capital Management, LLC on X

Disagree. Irrelevant. $ZD sold a single business segment for more than its entire market cap and I'm not even sure it was 20% of total revenues. $CBIZ another example. If $MNRO is selling separate segments to separate entities then even less relevant. In regards to the dividend, that too, makes zero sense. Why would they get financing that carves out (excepts) the December dividend and then go ahead and cancel it? They're telling you they expect to sell the company by the time they report earnings again.
@StableBread

Fajasy on X

Quantum $QMCO, which restated its financials in May 2024 and again in August 2025, just filed a September-quarter 10-Q that no longer says when it’ll fix the gaps in its accounting controls, including one it expected to fix by September 30. $QMCO’s disclosure controls are still “not effective” because of material weaknesses (the most serious kind of gap in a company’s financial reporting controls) that “remain unremediated as of September 30, 2026.” The weaknesses cover revenue recognition, inventories, income taxes, and the control environment, which the June-quarter 10-Q described as too few qualified staff and too little monitoring. $QMCO said in that June-quarter 10-Q, filed August 11, that it expected to automate the dates on the schedules that set when service revenue is recognized “by the end of our second fiscal quarter,” which ended September 30. The September-quarter 10-Q only says $QMCO “continued to implement” controls over those schedules, without saying whether the automation is in place. Nor does it repeat the June-quarter 10-Q’s other target dates: December 31, 2026 for inventory controls, and March 31, 2027 for sales order entry and income taxes. During the quarter, $QMCO hired a chief accounting officer and a director of tax, and engaged an outside consulting firm to help design the fixes. Management still concluded that the financial statements “fairly present in all material respects” $QMCO’s results. In my October 28 update, I said I’d first watch whether this 10-Q arrived on time, left past quarters unrestated, and showed the service revenue fix $QMCO targeted for the September quarter. There was no late filing or restatement, which I said may push the multiple toward my bear case’s 1.2x, but the 10-Q doesn’t show the fix. So I’d rather see the December-quarter 10-Q, due February 9, 2027, confirm the service revenue fix and give new dates for the rest before taking $QMCO at its word on its controls.

Investor Letters

All letters

The 10-Q Fills In the Buyback

Empire State Realty Trust bought $86.1 million of stock through November 6, while corrected sum-of-the-parts values range from $9.12 to…

ESRT $1.3B
Orphan REITs 1 click

No title

SpaceX’s $24 billion Starbase power plant, Microsoft’s Oracle capacity cuts, Riot’s $72 billion AI lease and Quanta’s sell-off frame…

RIOT $5.8B
Monte Independent Investment Research 1 click

Lion Copper: Initiation Report

Lion Copper targets 2030 Nevada copper production at Yerington, with Rio Tinto’s Nuton funding its 2027 feasibility study under a 65%…

LCU $96M
Atrium Research - Equity Research 2 clicks

Quick Value #337 - Dana Inc (DAN)

Dana is combining with Eaton’s Mobility unit via a 1Q27 Reverse Morris Trust after selling a division, delevering and accelerating buybacks.

DAN $2.1B
Value Don't Lie 2 clicks

Seed Corn

Chiron’s failed $49 million Beaumont sale and $178 million Pinnacle acquisition leave XRN with $70 million of liquidity and medical-office…

XRN $372M
Orphan REITs 2 clicks
OPRX · long

Optimizerx CORP

OptimizeRx, OPRX, trades 30% below its February 2025 writeup despite becoming a stronger company.

OPRX $163M
Value Investors Club 2 clicks

GAMCO Investors, Inc. - GAMI

GAMCO Investors trades OTC at a $550 million market cap, with $150 million in excess cash and a 5.2-5.7x operating-income valuation despite…

GAMI $537M
Exploring with Alluvial Capital

RH - the Universe Intervenes?

RH’s debt-funded luxury expansion faces weakening demand, deeper member discounts and a balance sheet strained by $2.4 billion of net debt.

RH $2.5B
Brevarthan Research 1 click

Acuren Q2 Earnings review

Acuren's Q2 revenue rose 1.5% to $313.9 million before its NV5 merger; post-close selling drove TIC down 21% as management targets $20…

TIC $2.3B
Kairos Research

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 79 of 282

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

368 firms

Sectors

Ordered by how often our editor reaches for them.